Tocqueville Asset Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Tocqueville Asset Management’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,432	Closed	-$37K	–	641
2022 Q3	$37K	Buy	3,432 +46	+1%	+$691	﹤0.01%	590
2022 Q2	$55K	Sell	3,386 -46	-1%	-$882	﹤0.01%	655
2022 Q1	$87K	Hold	3,432	–	–	﹤0.01%	696
2021 Q4	$72K	Buy	3,432 +1,182	+53%	+$40K	﹤0.01%	733
2021 Q3	$105K	Buy	2,250 +1,045	+87%	+$52.9K	﹤0.01%	716
2021 Q2	$74K	Buy	1,205 +273	+29%	+$24.8K	﹤0.01%	731
2021 Q1	$98K	Buy	+932	New	+$128K	﹤0.01%	712

Other funds holding ONCS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Tocqueville Asset Management's ONCS Position: Q4 2022 in Review

Tocqueville Asset Management sold out of OncoSec Medical Incorporated (ONCS) in Q4 2022, closing a stake of 3,432 shares — an estimated $37K sold.

Tocqueville Asset Management first reported a position in ONCS in Q1 2021 and held it in 7 quarters. The position peaked at $105K in Q3 2021. 17 funds tracked by Wall St. Rank hold ONCS as of Q4 2022.

Tocqueville Asset Management reported no remaining OncoSec Medical Incorporated position as of Q4 2022 after selling out during the quarter.
Tocqueville Asset Management sold 3,432 OncoSec Medical Incorporated shares in Q4 2022, an estimated $37K.
Tocqueville Asset Management first reported a position in OncoSec Medical Incorporated in Q1 2021 and held it in 7 quarters.
Tocqueville Asset Management's OncoSec Medical Incorporated position peaked at $105K in Q3 2021.
17 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2022.

Based on Tocqueville Asset Management's 13F filing for Q4 2022, filed 9 Feb 2023.